Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04641078Phase 2Unknown
Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer
Metastatic CancerOligometastasisProstate Cancer+2 more
PrincipalinvestigatorStart date: 2021-02-12
NCT03526562Not ApplicableCompleted
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
Castration-resistant Prostate CancerExercisePhysical Activity+1 more
PrincipalinvestigatorStart date: 2018-01-15
NCT02406183Phase 1Completed
Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma
Adverse Effect of Radiation TherapyEffects of ImmunotherapyMelanoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04641078Phase 2PrincipalInvestigator

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Metastatic CancerOligometastasisProstate Cancer+2 more
Unknown
NCT03526562Not ApplicablePrincipalInvestigator

Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients

Castration-resistant Prostate CancerExercisePhysical Activity+1 more
Completed
NCT02406183Phase 1PrincipalInvestigator

Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma

Adverse Effect of Radiation TherapyEffects of ImmunotherapyMelanoma
Completed

All 3 trials loaded